-+ 0.00%
-+ 0.00%
-+ 0.00%

Aldeyra Therapeutics Announces FDA Acceptance of Reproxalap NDA for Dry Eye Disease with PDUFA Target Date Set for December 2025

Reuters·07/17/2025 11:00:37

Please log in to view news